Literature DB >> 26403580

Clinical role of early dynamic FDG-PET/CT for the evaluation of renal cell carcinoma.

Reiko Nakajima1, Koichiro Abe2, Tsunenori Kondo3, Kazunari Tanabe3, Shuji Sakai1.   

Abstract

OBJECTIVES: We studied the usefulness of early dynamic (ED) and whole-body (WB) FDG-PET/CT for the evaluation of renal cell carcinoma (RCC).
METHODS: One hundred patients with 107 tumours underwent kidney ED and WB FDG-PET/CT. We visually and semiquantitatively evaluated the FDG accumulation in RCCs in the ED and WB phases, and compared the accumulation values with regard to histological type (clear cell carcinoma [CCC] vs. non-clear cell carcinoma [N-CCC]), the TNM stage (high stage [3-4] vs. low stage [1-2]), the Fuhrman grade (high grade [3-4] vs. low grade [1-2]) and presence versus absence of venous (V) and lymphatic (Ly) invasion.
RESULTS: In the ED phase, visual evaluation revealed no significant differences in FDG accumulation in terms of each item. However, the maximum standardized uptake value and tumour-to-normal tissue ratios were significantly higher in the CCCs compared to the N-CCCs (p < 0.001). In the WB phase, in contrast, significantly higher FDG accumulation (p < 0.001) was found in RCCs with a higher TNM stage, higher Furman grade, and the presence of V and Ly invasion in both the visual and the semiquantitative evaluations.
CONCLUSIONS: ED and WB FDG-PET/CT is a useful tool for the evaluation of RCCs. KEY POINTS: • ED and WB FDG-PET/ CT helps to assess patients with RCC • ED FDG-PET/CT enabled differentiation between CCC and N-CCC • FDG accumulation in the WB phase reflects tumour aggressiveness • Management of RCC is improved by ED and WB FDG-PET/CT.

Entities:  

Keywords:  Early dynamic; FDG-PET/CT; Fuhrman grade; Renal cell carcinoma; TNM stage

Mesh:

Substances:

Year:  2015        PMID: 26403580     DOI: 10.1007/s00330-015-4026-3

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  22 in total

1.  Efficiency of [(18)F]FDG PET in characterising renal cancer and detecting distant metastases: a comparison with CT.

Authors:  Nicolas Aide; Olivier Cappele; Philippe Bottet; Henri Bensadoun; Armelle Regeasse; François Comoz; Franck Sobrio; Gérard Bouvard; Denis Agostini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-07-04       Impact factor: 9.236

2.  Early dynamic 18F-FDG PET to detect hyperperfusion in hepatocellular carcinoma liver lesions.

Authors:  Jan-Henning Schierz; Thomas Opfermann; Jörg Steenbeck; Eric Lopatta; Utz Settmacher; Andreas Stallmach; Robert J Marlowe; Martin Freesmeyer
Journal:  J Nucl Med       Date:  2013-03-25       Impact factor: 10.057

3.  18-F fluorodeoxyglucose uptake in positron emission tomography as a pathological grade predictor for renal clear cell carcinomas.

Authors:  Yoshifumi Noda; Masayuki Kanematsu; Satoshi Goshima; Natsuko Suzui; Yoshinobu Hirose; Kengo Matsunaga; Hironori Nishibori; Hiroshi Kondo; Haruo Watanabe; Hiroshi Kawada; Nobuyuki Kawai; Yukichi Tanahashi; Kyongtae T Bae
Journal:  Eur Radiol       Date:  2015-04-09       Impact factor: 5.315

4.  Multiparametric magnetic resonance imaging for the differentiation of low and high grade clear cell renal carcinoma.

Authors:  F Cornelis; E Tricaud; A S Lasserre; F Petitpierre; J C Bernhard; Y Le Bras; M Yacoub; M Bouzgarrou; A Ravaud; N Grenier
Journal:  Eur Radiol       Date:  2014-08-13       Impact factor: 5.315

5.  A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses.

Authors:  Tamer Ozülker; Filiz Ozülker; Emin Ozbek; Tevfik Ozpaçaci
Journal:  Nucl Med Commun       Date:  2011-04       Impact factor: 1.690

6.  Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma.

Authors:  John C Cheville; Christine M Lohse; Horst Zincke; Amy L Weaver; Michael L Blute
Journal:  Am J Surg Pathol       Date:  2003-05       Impact factor: 6.394

7.  Role of F18-FDG-PET/CT in restaging patients affected by renal carcinoma.

Authors:  Francesco Bertagna; Federica Motta; Mattia Bertoli; Giovanni Bosio; Simona Fisogni; Regina Tardanico; Vittorio Ferrari; Alessandro Antonelli; Claudio Simeone; Sergio Cosciani Cunico; Raffaele Giubbini
Journal:  Nucl Med Rev Cent East Eur       Date:  2013

8.  Differences in organ system of distant metastasis by renal cell carcinoma subtype.

Authors:  Nathan E Hoffmann; Michael D Gillett; John C Cheville; Christine M Lohse; Bradley C Leibovich; Michael L Blute
Journal:  J Urol       Date:  2008-02       Impact factor: 7.450

9.  Microvascular tumour invasion in renal cell carcinoma: the most important prognostic factor.

Authors:  Marcos F Dall'Oglio; Alberto A Antunes; Alvaro S Sarkis; Alexandre Crippa; Kátia R Leite; Antonio Marmo Lucon; Miguel Srougi
Journal:  BJU Int       Date:  2007-06-06       Impact factor: 5.588

10.  Prognostic significance of morphologic parameters in renal cell carcinoma.

Authors:  S A Fuhrman; L C Lasky; C Limas
Journal:  Am J Surg Pathol       Date:  1982-10       Impact factor: 6.394

View more
  8 in total

Review 1.  PET imaging in renal cancer.

Authors:  Liza Lindenberg; Esther Mena; Peter L Choyke; Kirsten Bouchelouche
Journal:  Curr Opin Oncol       Date:  2019-05       Impact factor: 3.645

Review 2.  Review of renal cell carcinoma and its common subtypes in radiology.

Authors:  Gavin Low; Guan Huang; Winnie Fu; Zaahir Moloo; Safwat Girgis
Journal:  World J Radiol       Date:  2016-05-28

3.  Differentiation of Clear Cell Renal Cell Carcinoma From Other Renal Cortical Tumors by Use of a Quantitative Multiparametric MRI Approach.

Authors:  Andreas M Hötker; Yousef Mazaheri; Andreas Wibmer; Christoph A Karlo; Junting Zheng; Chaya S Moskowitz; Satish K Tickoo; Paul Russo; Hedvig Hricak; Oguz Akin
Journal:  AJR Am J Roentgenol       Date:  2017-01-17       Impact factor: 3.959

4.  Efficacy of Pre-operative 18F-FDG PET/CT in Prognostic Prediction in Patients With Renal Cell Carcinoma.

Authors:  Masafumi Toguchi; Kousei Ishigami; Masato Goya; Seiichi Saito; Sadayuki Murayama; Akihiro Nishie
Journal:  Cancer Diagn Progn       Date:  2022-03-03

Review 5.  Update on advances in molecular PET in urological oncology.

Authors:  Kazuhiro Kitajima; Shingo Yamamoto; Kazuhito Fukushima; Ryogo Minamimoto; Takao Kamai; Hossein Jadvar
Journal:  Jpn J Radiol       Date:  2016-05-24       Impact factor: 2.374

6.  18Fluorodeoxyglucose-positron emission tomography/computed tomography for differentiation of renal tumors in hereditary kidney cancer syndromes.

Authors:  Moozhan Nikpanah; Anna K Paschall; Mark A Ahlman; Ali Cahid Civelek; Faraz Farhadi; S Mojdeh Mirmomen; Xiaobai Li; Babak Saboury; Mark W Ball; Maria J Merino; Ramaprasad Srinivasan; Elizabeth C Jones; W Marston Linehan; Ashkan A Malayeri
Journal:  Abdom Radiol (NY)       Date:  2021-03-10

Review 7.  PET-CT and PET-MR in urological cancers other than prostate cancer: An update on state of the art.

Authors:  Abdul Razik; Chandan Jyoti Das; Sanjay Sharma
Journal:  Indian J Urol       Date:  2018 Jan-Mar

Review 8.  FAPI PET/CT in the Diagnosis of Abdominal and Pelvic Tumors.

Authors:  Tianshuo Yang; Long Ma; Haodong Hou; Feng Gao; Weijing Tao
Journal:  Front Oncol       Date:  2022-01-04       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.